Weight Loss

FDA Set to Approve New Weight-Loss Drug Contrave

| by Kate Wharmby Seldman

A panel of experts at the US Food and Drug Administration has recommended that the FDA approve Contrave as a weight-loss drug.

The new medication is not a diet pill per se: it's a combination of an anti-depressant and an anti-addiction medication, and it's aimed at combating the psychological causes of obesity.

Its antidepressant component, bupropion, is the same ingredient in popular antidepressant medication Wellbutrin and anti-smoking drug Zyban. Naltrexone is commonly used to treat opioid and alcohol dependency.

Contrave is the first weight-loss drug that the FDA has come close to approving in recent months: it rejected two others in October because of worries about safety. The panel of experts did, however, recommend that additional studies be conducted on possible heart risks.

Popular Video

This young teenage singer was shocked when Keith Urban invited her on stage at his concert. A few moments later, he made her wildest dreams come true.

The FDA will make a final decision on Contrave by January 31.